臨床試驗

Continuous Delivery of Ranibizumab Via the Port Delivery System for Proliferative Diabetic Retinopathy-related Vitreous Hemorrhage With Pars Plana Vitrectomy and Limited PRP.

NCT：NCT07864480 · NOT_YET_RECRUITING

NCT IDNCT07864480

狀態NOT_YET_RECRUITING

SponsorSoutheast Retina Center, Georgia (OTHER)

First posted2026-10-07

Last updated2026-10-07

簡要摘要

In Prolifertive Diabetic Retinopathy eyes with bleeding known as vitreous hemorrhage (VH) requiring a surgical procedure to remove the vitreous, called a vitrectomy, we will determine if the benefit and safety of adding a small implant that will be filled with medication called Susvimo is better with limited laser treatment.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。